Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Amphibian may hold key to curing cirrhosis
The liver of the Siphonops annulatus could help to cure cirrhosis in humans.

Unique liver cells break down the protein collagen

A South American amphibian could hold the key to curing cirrhosis, according to new research.

Researchers found the liver of Siphonops annulatus contains unique liver cells - known as melanomacrophages - which can remove and break down the protein collagen. In turn, this helps to minimise unwanted inflammation and reduce scar tissue which can lead to cirrhosis.

Study author Dr Augusto Coppi from the University of Surrey said: “The liver function of this amphibian, Siphonops annulatus, may provide us with a unique opportunity to solve one of the most devastating illnesses of the liver.

“We do need further in-depth investigations into how this discovery can be translated into humans, but it may have the potential to alter how we view and treat this disease.”

Cirrhosis occurs in response to liver damage. Hepatitis, chronic alcoholism or other harmful substances can all prompt the response of self-repair in the liver, which manifests as a high production of collagen and scar tissue.

As the condition progresses, liver functions such as cleaning blood become difficult. Several treatment strategies for cirrhosis have been attempted across the world including delaying or removing the underlying stimulus that causes scar tissue to form.

Dr Robson Gutierre from the Federal University of Sao Paulo said: “The ability this species has to break down its natural defences could also provide insight into immunity tolerance, a mechanism by which the liver can minimise unwanted inflammations.

"|mmunity tolerance can be studied in this species because they produce pro-inflammatory cells in the hematopoietic liver throughout its whole life, without developing chronic inflammations.”
 
The study, Melanomacrophage functions in the liver of the caecilian Siphonops annulatus, is published in The Journal of Anatomy.

Image (C) Andreas Schlüter

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
New guidance for antibiotic use in rabbits

New best practice guidance on the responsible use of antibiotics in rabbits has been published by the BSAVA in collaboration with the Rabbit Welfare Association & Fund (RWA&F).

The guidance is free and has been produced to help veterinary practitioners select the most appropriate antibiotic for rabbits. It covers active substance, dose and route of administration all of which are crucial factors when treating rabbits owing to the risk of enterotoxaemia.

For more information and to access the guide, visit the BSAVALibrary.